FILENAME	SEQ	COMPOUND_NAME	MOLECULEMASS	INSTRUMENT	IONSOURCE	EXTRACTSCAN	SMILES	INCHI	INCHIAUX	CHARGE	IONMODE	PUBMED	ACQUISITION	EXACTMASS	DATACOLLECTOR	ADDUCT	INTEREST	LIBQUALITY	GENUS	SPECIES	STRAIN	CASNUMBER	PI
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Contaminant vial septum ThermoFisher C5000-44B [IIN based]	628.1944	Orbitrap	LC-ESI	13	N/A	N/A	N/A	0	Positive	N/A	Other	610.1602	Robin Schmid	[M+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Contaminant vial septum ThermoFisher C5000-44B [IIN based]	593.1571	Orbitrap	LC-ESI	790	N/A	N/A	N/A	0	Positive	N/A	Other	610.1602	Robin Schmid	[M-H2O+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Spectral Match to Bis(2-ethylhexyl) phthalate from NIST14 [IIN based]	413.2658	Orbitrap	LC-ESI	389	N/A	N/A	N/A	0	Positive	N/A	Other	390.2768	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Spectral Match to Bis(2-ethylhexyl) phthalate from NIST14 [IIN based]	391.2841	Orbitrap	LC-ESI	555	N/A	N/A	N/A	0	Positive	N/A	Other	390.2768	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Contaminant vial septum ThermoFisher C5000-44B [IIN based]	707.1677	Orbitrap	LC-ESI	120	N/A	N/A	N/A	0	Positive	N/A	Other	684.1791	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Contaminant vial septum ThermoFisher C5000-44B [IIN based]	702.2131	Orbitrap	LC-ESI	25	N/A	N/A	N/A	0	Positive	N/A	Other	684.1791	Robin Schmid	[M+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	2-(7-methoxy-2-oxochromen-8-yl)-3-methylbut-2-enal [IIN based]	259.0961	Orbitrap	LC-ESI	491	N/A	InChI=1S/C15H14O4/c1-9(2)11(8-16)14-12(18-3)6-4-10-5-7-13(17)19-15(10)14/h4-8H,1-3H3	N/A	0	Positive	N/A	Other	276.0993	Robin Schmid	[M-H2O+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	2-(7-methoxy-2-oxochromen-8-yl)-3-methylbut-2-enal [IIN based]	299.0887	Orbitrap	LC-ESI	104	N/A	InChI=1S/C15H14O4/c1-9(2)11(8-16)14-12(18-3)6-4-10-5-7-13(17)19-15(10)14/h4-8H,1-3H3	N/A	0	Positive	N/A	Other	276.0993	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	2-(7-methoxy-2-oxochromen-8-yl)-3-methylbut-2-enal [IIN based]	294.1333	Orbitrap	LC-ESI	297	N/A	InChI=1S/C15H14O4/c1-9(2)11(8-16)14-12(18-3)6-4-10-5-7-13(17)19-15(10)14/h4-8H,1-3H3	N/A	0	Positive	N/A	Other	276.0993	Robin Schmid	[M+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Contaminant vial septum ThermoFisher C5000-44B [IIN based]	776.2317	Orbitrap	LC-ESI	64	N/A	N/A	N/A	0	Positive	N/A	Other	758.1979	Robin Schmid	[M+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Contaminant vial septum ThermoFisher C5000-44B [IIN based]	781.1873	Orbitrap	LC-ESI	238	N/A	N/A	N/A	0	Positive	N/A	Other	758.1979	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Contaminant vial septum ThermoFisher C5000-44B [IIN based]	557.0940	Orbitrap	LC-ESI	2191	N/A	N/A	N/A	0	Positive	N/A	Other	518.1294	Robin Schmid	[M+K]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Contaminant vial septum ThermoFisher C5000-44B [IIN based]	541.1157	Orbitrap	LC-ESI	2182	N/A	N/A	N/A	0	Positive	N/A	Other	518.1294	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Contaminant vial septum ThermoFisher C5000-44B [IIN based]	519.1383	Orbitrap	LC-ESI	1008	N/A	N/A	N/A	0	Positive	N/A	Other	518.1294	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	7-O-beta-glucopyranosyl-4'-hydroxy-5-methoxyisoflavone [IIN based]	447.1280	Orbitrap	LC-ESI	118	N/A	InChI=1S/C22H22O10/c1-29-14-6-12(31-22-21(28)20(27)19(26)16(8-23)32-22)7-15-17(14)18(25)13(9-30-15)10-2-4-11(24)5-3-10/h2-7,9,16,19-24,26-28H,8H2,1H3/t16-,19-,20+,21-,22-/m1/s1	N/A	0	Positive	N/A	Other	446.1206	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	7-O-beta-glucopyranosyl-4'-hydroxy-5-methoxyisoflavone [IIN based]	469.1102	Orbitrap	LC-ESI	256	N/A	InChI=1S/C22H22O10/c1-29-14-6-12(31-22-21(28)20(27)19(26)16(8-23)32-22)7-15-17(14)18(25)13(9-30-15)10-2-4-11(24)5-3-10/h2-7,9,16,19-24,26-28H,8H2,1H3/t16-,19-,20+,21-,22-/m1/s1	N/A	0	Positive	N/A	Other	446.1206	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Didodecyl 3,3'-thiodipropionate [IIN based]	537.3942	Orbitrap	LC-ESI	57	CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC	InChI=1S/C30H58O4S/c1-3-5-7-9-11-13-15-17-19-21-25-33-29(31)23-27-35-28-24-30(32)34-26-22-20-18-16-14-12-10-8-6-4-2/h3-28H2,1-2H3	N/A	0	Positive	N/A	Other	514.4049	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Didodecyl 3,3'-thiodipropionate [IIN based]	515.4117	Orbitrap	LC-ESI	353	CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC	InChI=1S/C30H58O4S/c1-3-5-7-9-11-13-15-17-19-21-25-33-29(31)23-27-35-28-24-30(32)34-26-22-20-18-16-14-12-10-8-6-4-2/h3-28H2,1-2H3	N/A	0	Positive	N/A	Other	514.4049	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Didodecyl 3,3'-thiodipropionate [IIN based]	532.4383	Orbitrap	LC-ESI	131	CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC	InChI=1S/C30H58O4S/c1-3-5-7-9-11-13-15-17-19-21-25-33-29(31)23-27-35-28-24-30(32)34-26-22-20-18-16-14-12-10-8-6-4-2/h3-28H2,1-2H3	N/A	0	Positive	N/A	Other	514.4049	Robin Schmid	[M+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	[5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl] 3,4-dihydroxy-2-methylidenebutanoate [IIN based]	433.1827	Orbitrap	LC-ESI	169	N/A	InChI=1S/C21H30O8/c1-7-21(5)8-15(29-20(27)12(3)14(24)10-23)16(13(4)19(26)28-6)18(25)17(21)11(2)9-22/h7,14-18,22-25H,1-4,8-10H2,5-6H3	N/A	0	Positive	N/A	Other	410.1933	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	[5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl] 3,4-dihydroxy-2-methylidenebutanoate [IIN based]	411.2008	Orbitrap	LC-ESI	360	N/A	InChI=1S/C21H30O8/c1-7-21(5)8-15(29-20(27)12(3)14(24)10-23)16(13(4)19(26)28-6)18(25)17(21)11(2)9-22/h7,14-18,22-25H,1-4,8-10H2,5-6H3	N/A	0	Positive	N/A	Other	410.1933	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	9-methoxy-7-[4-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]-[1,3]dioxolo[4,5-g]chromen-8-one [IIN based]	637.1753	Orbitrap	LC-ESI	210	N/A	InChI=1S/C29H32O16/c1-38-27-18-14(6-15-26(27)42-10-41-15)39-8-13(19(18)31)11-2-4-12(5-3-11)43-29-25(37)23(35)21(33)17(45-29)9-40-28-24(36)22(34)20(32)16(7-30)44-28/h2-6,8,16-17,20-25,28-30,32-37H,7,9-10H2,1H3	N/A	0	Positive	N/A	Other	636.1681	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	9-methoxy-7-[4-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]-[1,3]dioxolo[4,5-g]chromen-8-one [IIN based]	659.1570	Orbitrap	LC-ESI	520	N/A	InChI=1S/C29H32O16/c1-38-27-18-14(6-15-26(27)42-10-41-15)39-8-13(19(18)31)11-2-4-12(5-3-11)43-29-25(37)23(35)21(33)17(45-29)9-40-28-24(36)22(34)20(32)16(7-30)44-28/h2-6,8,16-17,20-25,28-30,32-37H,7,9-10H2,1H3	N/A	0	Positive	N/A	Other	636.1681	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	9-methoxy-7-[4-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]-[1,3]dioxolo[4,5-g]chromen-8-one [IIN based]	338.0650	Orbitrap	LC-ESI	1497	N/A	InChI=1S/C29H32O16/c1-38-27-18-14(6-15-26(27)42-10-41-15)39-8-13(19(18)31)11-2-4-12(5-3-11)43-29-25(37)23(35)21(33)17(45-29)9-40-28-24(36)22(34)20(32)16(7-30)44-28/h2-6,8,16-17,20-25,28-30,32-37H,7,9-10H2,1H3	N/A	0	Positive	N/A	Other	636.1681	Robin Schmid	[M+Ca]2+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	4-hydroxy-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one [IIN based]	401.1223	Orbitrap	LC-ESI	571	N/A	InChI=1S/C21H20O8/c1-25-13-4-9(5-14(26-2)19(13)23)16-11-6-15-20(29-8-28-15)18(22)12(11)3-10-7-27-21(24)17(10)16/h4-6,10,16-17,22-23H,3,7-8H2,1-2H3	N/A	0	Positive	N/A	Other	400.1153	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	4-hydroxy-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one [IIN based]	418.1497	Orbitrap	LC-ESI	101	N/A	InChI=1S/C21H20O8/c1-25-13-4-9(5-14(26-2)19(13)23)16-11-6-15-20(29-8-28-15)18(22)12(11)3-10-7-27-21(24)17(10)16/h4-6,10,16-17,22-23H,3,7-8H2,1-2H3	N/A	0	Positive	N/A	Other	400.1153	Robin Schmid	[M+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	6-[(3E,6E)-2,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-3,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN based]	435.2376	Orbitrap	LC-ESI	95	N/A	InChI=1S/C24H34O7/c1-12(10-22(6,27)19-14(3)18(28-9)15(4)20(26)29-19)17(25)13(2)11-23(7)21-24(8,31-21)16(5)30-23/h10-11,16-17,21,25,27H,1-9H3/b12-10+,13-11+	N/A	0	Positive	N/A	Other	434.2302	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	6-[(3E,6E)-2,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-3,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN based]	493.2903	Orbitrap	LC-ESI	255	N/A	InChI=1S/C24H34O7/c1-12(10-22(6,27)19-14(3)18(28-9)15(4)20(26)29-19)17(25)13(2)11-23(7)21-24(8,31-21)16(5)30-23/h10-11,16-17,21,25,27H,1-9H3/b12-10+,13-11+	N/A	0	Positive	N/A	Other	434.2302	Robin Schmid	[M+ACN+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	6-[(3E,6E)-2,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-3,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN based]	891.4490	Orbitrap	LC-ESI	795	N/A	InChI=1S/C24H34O7/c1-12(10-22(6,27)19-14(3)18(28-9)15(4)20(26)29-19)17(25)13(2)11-23(7)21-24(8,31-21)16(5)30-23/h10-11,16-17,21,25,27H,1-9H3/b12-10+,13-11+	N/A	0	Positive	N/A	Other	434.2302	Robin Schmid	[2M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	6-[(3E,6E)-2,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-3,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN based]	399.2165	Orbitrap	LC-ESI	307	N/A	InChI=1S/C24H34O7/c1-12(10-22(6,27)19-14(3)18(28-9)15(4)20(26)29-19)17(25)13(2)11-23(7)21-24(8,31-21)16(5)30-23/h10-11,16-17,21,25,27H,1-9H3/b12-10+,13-11+	N/A	0	Positive	N/A	Other	434.2302	Robin Schmid	[M-2H2O+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	6-[(3E,6E)-2,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-3,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN based]	417.2269	Orbitrap	LC-ESI	502	N/A	InChI=1S/C24H34O7/c1-12(10-22(6,27)19-14(3)18(28-9)15(4)20(26)29-19)17(25)13(2)11-23(7)21-24(8,31-21)16(5)30-23/h10-11,16-17,21,25,27H,1-9H3/b12-10+,13-11+	N/A	0	Positive	N/A	Other	434.2302	Robin Schmid	[M-H2O+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	7-Hydroxy-2'-methoxyflavone [IIN based]	269.0805	Orbitrap	LC-ESI	14	COC1=CC=CC=C1C2=CC(=O)C3=C(O2)C=C(C=C3)O	InChI=1S/C16H12O4/c1-19-14-5-3-2-4-12(14)16-9-13(18)11-7-6-10(17)8-15(11)20-16/h2-9,17H,1H3	N/A	0	Positive	N/A	Other	268.0732	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Asterric acid [IIN based]	349.0915	Orbitrap	LC-ESI	772	CC1=CC(=C(C(=C1)OC2=C(C=C(C=C2C(=O)OC)O)OC)C(=O)O)O	InChI=1S/C17H16O8/c1-8-4-11(19)14(16(20)21)12(5-8)25-15-10(17(22)24-3)6-9(18)7-13(15)23-2/h4-7,18-19H,1-3H3,(H,20,21)	N/A	0	Positive	N/A	Other	348.0841	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Asterric acid [IIN based]	371.0733	Orbitrap	LC-ESI	588	CC1=CC(=C(C(=C1)OC2=C(C=C(C=C2C(=O)OC)O)OC)C(=O)O)O	InChI=1S/C17H16O8/c1-8-4-11(19)14(16(20)21)12(5-8)25-15-10(17(22)24-3)6-9(18)7-13(15)23-2/h4-7,18-19H,1-3H3,(H,20,21)	N/A	0	Positive	N/A	Other	348.0841	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Destruxin A [IIN based]	578.3543	Orbitrap	LC-ESI	15	CCC(C)C1C(=O)N(C(C(=O)N(C(C(=O)NCCC(=O)OC(C(=O)N2CCCC2C(=O)N1)CC=C)C)C)C(C)C)C	InChI=1S/C29H47N5O7/c1-9-12-21-27(38)34-16-11-13-20(34)26(37)31-23(18(5)10-2)28(39)33(8)24(17(3)4)29(40)32(7)19(6)25(36)30-15-14-22(35)41-21/h9,17-21,23-24H,1,10-16H2,2-8H3,(H,30,36)(H,31,37)/t18-,19+,20+,21+,23+,24+/m1/s1	N/A	0	Positive	N/A	Other	577.3466	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Destruxin A [IIN based]	636.4071	Orbitrap	LC-ESI	350	CCC(C)C1C(=O)N(C(C(=O)N(C(C(=O)NCCC(=O)OC(C(=O)N2CCCC2C(=O)N1)CC=C)C)C)C(C)C)C	InChI=1S/C29H47N5O7/c1-9-12-21-27(38)34-16-11-13-20(34)26(37)31-23(18(5)10-2)28(39)33(8)24(17(3)4)29(40)32(7)19(6)25(36)30-15-14-22(35)41-21/h9,17-21,23-24H,1,10-16H2,2-8H3,(H,30,36)(H,31,37)/t18-,19+,20+,21+,23+,24+/m1/s1	N/A	0	Positive	N/A	Other	577.3466	Robin Schmid	[M+ACN+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Destruxin A [IIN based]	308.6539	Orbitrap	LC-ESI	1323	CCC(C)C1C(=O)N(C(C(=O)N(C(C(=O)NCCC(=O)OC(C(=O)N2CCCC2C(=O)N1)CC=C)C)C)C(C)C)C	InChI=1S/C29H47N5O7/c1-9-12-21-27(38)34-16-11-13-20(34)26(37)31-23(18(5)10-2)28(39)33(8)24(17(3)4)29(40)32(7)19(6)25(36)30-15-14-22(35)41-21/h9,17-21,23-24H,1,10-16H2,2-8H3,(H,30,36)(H,31,37)/t18-,19+,20+,21+,23+,24+/m1/s1	N/A	0	Positive	N/A	Other	577.3466	Robin Schmid	[M+Ca]2+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Destruxin A [IIN based]	600.3359	Orbitrap	LC-ESI	38	CCC(C)C1C(=O)N(C(C(=O)N(C(C(=O)NCCC(=O)OC(C(=O)N2CCCC2C(=O)N1)CC=C)C)C)C(C)C)C	InChI=1S/C29H47N5O7/c1-9-12-21-27(38)34-16-11-13-20(34)26(37)31-23(18(5)10-2)28(39)33(8)24(17(3)4)29(40)32(7)19(6)25(36)30-15-14-22(35)41-21/h9,17-21,23-24H,1,10-16H2,2-8H3,(H,30,36)(H,31,37)/t18-,19+,20+,21+,23+,24+/m1/s1	N/A	0	Positive	N/A	Other	577.3466	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Destruxin A [IIN based]	1177.6815	Orbitrap	LC-ESI	1227	CCC(C)C1C(=O)N(C(C(=O)N(C(C(=O)NCCC(=O)OC(C(=O)N2CCCC2C(=O)N1)CC=C)C)C)C(C)C)C	InChI=1S/C29H47N5O7/c1-9-12-21-27(38)34-16-11-13-20(34)26(37)31-23(18(5)10-2)28(39)33(8)24(17(3)4)29(40)32(7)19(6)25(36)30-15-14-22(35)41-21/h9,17-21,23-24H,1,10-16H2,2-8H3,(H,30,36)(H,31,37)/t18-,19+,20+,21+,23+,24+/m1/s1	N/A	0	Positive	N/A	Other	577.3466	Robin Schmid	[2M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	zapotin [IIN based]	343.1173	Orbitrap	LC-ESI	4	N/A	InChI=1S/C19H18O6/c1-21-12-6-5-7-13(22-2)18(12)16-10-11(20)17-14(25-16)8-9-15(23-3)19(17)24-4/h5-10H,1-4H3	N/A	0	Positive	N/A	Other	342.1100	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	zapotin [IIN based]	707.2089	Orbitrap	LC-ESI	248	N/A	InChI=1S/C19H18O6/c1-21-12-6-5-7-13(22-2)18(12)16-10-11(20)17-14(25-16)8-9-15(23-3)19(17)24-4/h5-10H,1-4H3	N/A	0	Positive	N/A	Other	342.1100	Robin Schmid	[2M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	zapotin [IIN based]	365.0993	Orbitrap	LC-ESI	50	N/A	InChI=1S/C19H18O6/c1-21-12-6-5-7-13(22-2)18(12)16-10-11(20)17-14(25-16)8-9-15(23-3)19(17)24-4/h5-10H,1-4H3	N/A	0	Positive	N/A	Other	342.1100	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	7-[(E)-3-methyl-4-(4-methyl-5-oxo-2H-furan-2-yl)but-2-enoxy]chromen-2-one [IIN based]	365.0772	Orbitrap	LC-ESI	2185	N/A	InChI=1S/C19H18O5/c1-12(9-16-10-13(2)19(21)23-16)7-8-22-15-5-3-14-4-6-18(20)24-17(14)11-15/h3-7,10-11,16H,8-9H2,1-2H3/b12-7+	N/A	0	Positive	N/A	Other	326.1152	Robin Schmid	[M+K]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	7-[(E)-3-methyl-4-(4-methyl-5-oxo-2H-furan-2-yl)but-2-enoxy]chromen-2-one [IIN based]	327.1222	Orbitrap	LC-ESI	22	N/A	InChI=1S/C19H18O5/c1-12(9-16-10-13(2)19(21)23-16)7-8-22-15-5-3-14-4-6-18(20)24-17(14)11-15/h3-7,10-11,16H,8-9H2,1-2H3/b12-7+	N/A	0	Positive	N/A	Other	326.1152	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	7-[(E)-3-methyl-4-(4-methyl-5-oxo-2H-furan-2-yl)but-2-enoxy]chromen-2-one [IIN based]	349.1042	Orbitrap	LC-ESI	65	N/A	InChI=1S/C19H18O5/c1-12(9-16-10-13(2)19(21)23-16)7-8-22-15-5-3-14-4-6-18(20)24-17(14)11-15/h3-7,10-11,16H,8-9H2,1-2H3/b12-7+	N/A	0	Positive	N/A	Other	326.1152	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	7-[(E)-3-methyl-4-(4-methyl-5-oxo-2H-furan-2-yl)but-2-enoxy]chromen-2-one [IIN based]	344.1508	Orbitrap	LC-ESI	2027	N/A	InChI=1S/C19H18O5/c1-12(9-16-10-13(2)19(21)23-16)7-8-22-15-5-3-14-4-6-18(20)24-17(14)11-15/h3-7,10-11,16H,8-9H2,1-2H3/b12-7+	N/A	0	Positive	N/A	Other	326.1152	Robin Schmid	[M+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	2-METHYL-5,7,8-TRIMETHOXYISOFLAVONE [IIN based]	367.1148	Orbitrap	LC-ESI	536	N/A	N/A	N/A	0	Positive	N/A	Other	344.1255	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	2-METHYL-5,7,8-TRIMETHOXYISOFLAVONE [IIN based]	327.1219	Orbitrap	LC-ESI	1612	N/A	N/A	N/A	0	Positive	N/A	Other	344.1255	Robin Schmid	[M-H2O+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	2-METHYL-5,7,8-TRIMETHOXYISOFLAVONE [IIN based]	345.1331	Orbitrap	LC-ESI	42	N/A	N/A	N/A	0	Positive	N/A	Other	344.1255	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Tunicamycin B [IIN based]	867.4196	Orbitrap	LC-ESI	695	CC(C)CCCCCCCCCCC=CC(=O)NC1C(C(C(OC1OC2C(C(C(C(O2)CO)O)O)NC(=O)C)CC(C3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)O)O)O	N/A	N/A	0	Positive	N/A	Other	844.4305	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Tunicamycin B [IIN based]	845.4379	Orbitrap	LC-ESI	257	CC(C)CCCCCCCCCCC=CC(=O)NC1C(C(C(OC1OC2C(C(C(C(O2)CO)O)O)NC(=O)C)CC(C3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)O)O)O	N/A	N/A	0	Positive	N/A	Other	844.4305	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Tunicamycin B [IIN based]	889.4018	Orbitrap	LC-ESI	1857	CC(C)CCCCCCCCCCC=CC(=O)NC1C(C(C(OC1OC2C(C(C(C(O2)CO)O)O)NC(=O)C)CC(C3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)O)O)O	N/A	N/A	0	Positive	N/A	Other	844.4305	Robin Schmid	[M-H+2Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Licochalcone A [IIN based]	303.1351	Orbitrap	LC-ESI	286	CC(C)(C=C)C1=C(C=C(C(=C1)C=CC(=O)C2=CC=C(C=C2)O)OC)O	InChI=1S/C21H22O4/c1-5-21(2,3)17-12-15(20(25-4)13-19(17)24)8-11-18(23)14-6-9-16(22)10-7-14/h5-13,22,24H,1H2,2-4H3/b11-8+	N/A	0	Positive	N/A	Other	316.1683	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Licochalcone A [IIN based]	281.1533	Orbitrap	LC-ESI	182	CC(C)(C=C)C1=C(C=C(C(=C1)C=CC(=O)C2=CC=C(C=C2)O)OC)O	InChI=1S/C21H22O4/c1-5-21(2,3)17-12-15(20(25-4)13-19(17)24)8-11-18(23)14-6-9-16(22)10-7-14/h5-13,22,24H,1H2,2-4H3/b11-8+	N/A	0	Positive	N/A	Other	316.1683	Robin Schmid	[M-2H2O+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Licochalcone A [IIN based]	339.1587	Orbitrap	LC-ESI	146	CC(C)(C=C)C1=C(C=C(C(=C1)C=CC(=O)C2=CC=C(C=C2)O)OC)O	InChI=1S/C21H22O4/c1-5-21(2,3)17-12-15(20(25-4)13-19(17)24)8-11-18(23)14-6-9-16(22)10-7-14/h5-13,22,24H,1H2,2-4H3/b11-8+	N/A	0	Positive	N/A	Other	316.1683	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Licochalcone A [IIN based]	303.1351	Orbitrap	LC-ESI	286	CC(C)(C=C)C1=C(C=C(C(=C1)C=CC(=O)C2=CC=C(C=C2)O)OC)O	InChI=1S/C21H22O4/c1-5-21(2,3)17-12-15(20(25-4)13-19(17)24)8-11-18(23)14-6-9-16(22)10-7-14/h5-13,22,24H,1H2,2-4H3/b11-8+	N/A	0	Positive	N/A	Other	316.1683	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Licochalcone A [IIN based]	281.1533	Orbitrap	LC-ESI	182	CC(C)(C=C)C1=C(C=C(C(=C1)C=CC(=O)C2=CC=C(C=C2)O)OC)O	InChI=1S/C21H22O4/c1-5-21(2,3)17-12-15(20(25-4)13-19(17)24)8-11-18(23)14-6-9-16(22)10-7-14/h5-13,22,24H,1H2,2-4H3/b11-8+	N/A	0	Positive	N/A	Other	316.1683	Robin Schmid	[M-2H2O+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Licochalcone A [IIN based]	303.1351	Orbitrap	LC-ESI	286	CC(C)(C=C)C1=C(C=C(C(=C1)C=CC(=O)C2=CC=C(C=C2)O)OC)O	InChI=1S/C21H22O4/c1-5-21(2,3)17-12-15(20(25-4)13-19(17)24)8-11-18(23)14-6-9-16(22)10-7-14/h5-13,22,24H,1H2,2-4H3/b11-8+	N/A	0	Positive	N/A	Other	316.1683	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Licochalcone A [IIN based]	303.1351	Orbitrap	LC-ESI	286	CC(C)(C=C)C1=C(C=C(C(=C1)C=CC(=O)C2=CC=C(C=C2)O)OC)O	InChI=1S/C21H22O4/c1-5-21(2,3)17-12-15(20(25-4)13-19(17)24)8-11-18(23)14-6-9-16(22)10-7-14/h5-13,22,24H,1H2,2-4H3/b11-8+	N/A	0	Positive	N/A	Other	316.1683	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Licochalcone A [IIN based]	339.1587	Orbitrap	LC-ESI	146	CC(C)(C=C)C1=C(C=C(C(=C1)C=CC(=O)C2=CC=C(C=C2)O)OC)O	InChI=1S/C21H22O4/c1-5-21(2,3)17-12-15(20(25-4)13-19(17)24)8-11-18(23)14-6-9-16(22)10-7-14/h5-13,22,24H,1H2,2-4H3/b11-8+	N/A	0	Positive	N/A	Other	316.1683	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Licochalcone A [IIN based]	303.1351	Orbitrap	LC-ESI	286	CC(C)(C=C)C1=C(C=C(C(=C1)C=CC(=O)C2=CC=C(C=C2)O)OC)O	InChI=1S/C21H22O4/c1-5-21(2,3)17-12-15(20(25-4)13-19(17)24)8-11-18(23)14-6-9-16(22)10-7-14/h5-13,22,24H,1H2,2-4H3/b11-8+	N/A	0	Positive	N/A	Other	316.1683	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Benz[a]anthracene-1,7,12(2H)-trione, 3,4-dihydro-8-hydroxy-3-methyl-, (3S)- [IIN based]	307.0960	Orbitrap	LC-ESI	200	CC1CC2=C(C(=O)C1)C3=C(C=C2)C(=O)C4=C(C3=O)C=CC=C4O	InChI=1S/C19H14O4/c1-9-7-10-5-6-12-17(15(10)14(21)8-9)19(23)11-3-2-4-13(20)16(11)18(12)22/h2-6,9,20H,7-8H2,1H3/t9-/m0/s1	N/A	0	Positive	N/A	Other	306.0888	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Karanjin [IIN based]	293.0805	Orbitrap	LC-ESI	5	COC1=C(OC2=C(C1=O)C=CC3=C2C=CO3)C4=CC=CC=C4	InChI=1S/C18H12O4/c1-20-18-15(19)13-7-8-14-12(9-10-21-14)17(13)22-16(18)11-5-3-2-4-6-11/h2-10H,1H3	N/A	0	Positive	N/A	Other	292.0730	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Karanjin [IIN based]	607.1354	Orbitrap	LC-ESI	410	COC1=C(OC2=C(C1=O)C=CC3=C2C=CO3)C4=CC=CC=C4	InChI=1S/C18H12O4/c1-20-18-15(19)13-7-8-14-12(9-10-21-14)17(13)22-16(18)11-5-3-2-4-6-11/h2-10H,1H3	N/A	0	Positive	N/A	Other	292.0730	Robin Schmid	[2M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Phyllanthin [IIN based]	441.2245	Orbitrap	LC-ESI	12	COCC(CC1=CC(=C(C=C1)OC)OC)C(CC2=CC(=C(C=C2)OC)OC)COC	InChI=1S/C24H34O6/c1-25-15-19(11-17-7-9-21(27-3)23(13-17)29-5)20(16-26-2)12-18-8-10-22(28-4)24(14-18)30-6/h7-10,13-14,19-20H,11-12,15-16H2,1-6H3/t19-,20-/m1/s1	N/A	0	Positive	N/A	Other	418.2351	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Phyllanthin [IIN based]	436.2689	Orbitrap	LC-ESI	19	COCC(CC1=CC(=C(C=C1)OC)OC)C(CC2=CC(=C(C=C2)OC)OC)COC	InChI=1S/C24H34O6/c1-25-15-19(11-17-7-9-21(27-3)23(13-17)29-5)20(16-26-2)12-18-8-10-22(28-4)24(14-18)30-6/h7-10,13-14,19-20H,11-12,15-16H2,1-6H3/t19-,20-/m1/s1	N/A	0	Positive	N/A	Other	418.2351	Robin Schmid	[M+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Phyllanthin [IIN based]	419.2426	Orbitrap	LC-ESI	234	COCC(CC1=CC(=C(C=C1)OC)OC)C(CC2=CC(=C(C=C2)OC)OC)COC	InChI=1S/C24H34O6/c1-25-15-19(11-17-7-9-21(27-3)23(13-17)29-5)20(16-26-2)12-18-8-10-22(28-4)24(14-18)30-6/h7-10,13-14,19-20H,11-12,15-16H2,1-6H3/t19-,20-/m1/s1	N/A	0	Positive	N/A	Other	418.2351	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Visnadin [IIN based]	799.2924	Orbitrap	LC-ESI	356	N/A	InChI=1S/C21H24O7/c1-6-11(2)20(24)27-19-18(25-12(3)22)16-14(28-21(19,4)5)9-7-13-8-10-15(23)26-17(13)16/h7-11,18-19H,6H2,1-5H3/t11-,18-,19-/m1/s1	N/A	0	Positive	N/A	Other	388.1516	Robin Schmid	[2M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Visnadin [IIN based]	411.1407	Orbitrap	LC-ESI	54	N/A	InChI=1S/C21H24O7/c1-6-11(2)20(24)27-19-18(25-12(3)22)16-14(28-21(19,4)5)9-7-13-8-10-15(23)26-17(13)16/h7-11,18-19H,6H2,1-5H3/t11-,18-,19-/m1/s1	N/A	0	Positive	N/A	Other	388.1516	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Visnadin [IIN based]	406.1855	Orbitrap	LC-ESI	20	N/A	InChI=1S/C21H24O7/c1-6-11(2)20(24)27-19-18(25-12(3)22)16-14(28-21(19,4)5)9-7-13-8-10-15(23)26-17(13)16/h7-11,18-19H,6H2,1-5H3/t11-,18-,19-/m1/s1	N/A	0	Positive	N/A	Other	388.1516	Robin Schmid	[M+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Schizandrin A [IIN based]	434.2534	Orbitrap	LC-ESI	68	CC1CC2=CC(=C(C(=C2C3=C(C(=C(C=C3CC1C)OC)OC)OC)OC)OC)OC	InChI=1S/C24H32O6/c1-13-9-15-11-17(25-3)21(27-5)23(29-7)19(15)20-16(10-14(13)2)12-18(26-4)22(28-6)24(20)30-8/h11-14H,9-10H2,1-8H3	N/A	0	Positive	N/A	Other	416.2193	Robin Schmid	[M+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Schizandrin A [IIN based]	855.4271	Orbitrap	LC-ESI	1255	CC1CC2=CC(=C(C(=C2C3=C(C(=C(C=C3CC1C)OC)OC)OC)OC)OC)OC	InChI=1S/C24H32O6/c1-13-9-15-11-17(25-3)21(27-5)23(29-7)19(15)20-16(10-14(13)2)12-18(26-4)22(28-6)24(20)30-8/h11-14H,9-10H2,1-8H3	N/A	0	Positive	N/A	Other	416.2193	Robin Schmid	[2M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Schizandrin A [IIN based]	417.2268	Orbitrap	LC-ESI	24	CC1CC2=CC(=C(C(=C2C3=C(C(=C(C=C3CC1C)OC)OC)OC)OC)OC)OC	InChI=1S/C24H32O6/c1-13-9-15-11-17(25-3)21(27-5)23(29-7)19(15)20-16(10-14(13)2)12-18(26-4)22(28-6)24(20)30-8/h11-14H,9-10H2,1-8H3	N/A	0	Positive	N/A	Other	416.2193	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Schizandrin A [IIN based]	439.2092	Orbitrap	LC-ESI	89	CC1CC2=CC(=C(C(=C2C3=C(C(=C(C=C3CC1C)OC)OC)OC)OC)OC)OC	InChI=1S/C24H32O6/c1-13-9-15-11-17(25-3)21(27-5)23(29-7)19(15)20-16(10-14(13)2)12-18(26-4)22(28-6)24(20)30-8/h11-14H,9-10H2,1-8H3	N/A	0	Positive	N/A	Other	416.2193	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Lasalocid [IIN based]	608.4152	Orbitrap	LC-ESI	11	CCC(C1C(CC(O1)(CC)C2CCC(C(O2)C)(CC)O)C)C(=O)C(C)C(C(C)CCC3=C(C(=C(C=C3)C)O)C(=O)O)O	InChI=1S/C34H54O8/c1-9-25(31-21(6)18-34(11-3,42-31)26-16-17-33(40,10-2)23(8)41-26)30(37)22(7)28(35)19(4)12-14-24-15-13-20(5)29(36)27(24)32(38)39/h13,15,19,21-23,25-26,28,31,35-36,40H,9-12,14,16-18H2,1-8H3,(H,38,39)/t19-,21+,22+,23+,25+,26-,28+,31+,33-,34+/m1/s1	N/A	0	Positive	N/A	Other	590.3806	Robin Schmid	[M+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Lasalocid [IIN based]	1225.7325	Orbitrap	LC-ESI	2230	CCC(C1C(CC(O1)(CC)C2CCC(C(O2)C)(CC)O)C)C(=O)C(C)C(C(C)CCC3=C(C(=C(C=C3)C)O)C(=O)O)O	InChI=1S/C34H54O8/c1-9-25(31-21(6)18-34(11-3,42-31)26-16-17-33(40,10-2)23(8)41-26)30(37)22(7)28(35)19(4)12-14-24-15-13-20(5)29(36)27(24)32(38)39/h13,15,19,21-23,25-26,28,31,35-36,40H,9-12,14,16-18H2,1-8H3,(H,38,39)/t19-,21+,22+,23+,25+,26-,28+,31+,33-,34+/m1/s1	N/A	0	Positive	N/A	Other	590.3806	Robin Schmid	[2M-H+2Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Lasalocid [IIN based]	555.3668	Orbitrap	LC-ESI	828	CCC(C1C(CC(O1)(CC)C2CCC(C(O2)C)(CC)O)C)C(=O)C(C)C(C(C)CCC3=C(C(=C(C=C3)C)O)C(=O)O)O	InChI=1S/C34H54O8/c1-9-25(31-21(6)18-34(11-3,42-31)26-16-17-33(40,10-2)23(8)41-26)30(37)22(7)28(35)19(4)12-14-24-15-13-20(5)29(36)27(24)32(38)39/h13,15,19,21-23,25-26,28,31,35-36,40H,9-12,14,16-18H2,1-8H3,(H,38,39)/t19-,21+,22+,23+,25+,26-,28+,31+,33-,34+/m1/s1	N/A	0	Positive	N/A	Other	590.3806	Robin Schmid	[M-2H2O+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Lasalocid [IIN based]	629.3430	Orbitrap	LC-ESI	2210	CCC(C1C(CC(O1)(CC)C2CCC(C(O2)C)(CC)O)C)C(=O)C(C)C(C(C)CCC3=C(C(=C(C=C3)C)O)C(=O)O)O	InChI=1S/C34H54O8/c1-9-25(31-21(6)18-34(11-3,42-31)26-16-17-33(40,10-2)23(8)41-26)30(37)22(7)28(35)19(4)12-14-24-15-13-20(5)29(36)27(24)32(38)39/h13,15,19,21-23,25-26,28,31,35-36,40H,9-12,14,16-18H2,1-8H3,(H,38,39)/t19-,21+,22+,23+,25+,26-,28+,31+,33-,34+/m1/s1	N/A	0	Positive	N/A	Other	590.3806	Robin Schmid	[M+K]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Lasalocid [IIN based]	591.3886	Orbitrap	LC-ESI	324	CCC(C1C(CC(O1)(CC)C2CCC(C(O2)C)(CC)O)C)C(=O)C(C)C(C(C)CCC3=C(C(=C(C=C3)C)O)C(=O)O)O	InChI=1S/C34H54O8/c1-9-25(31-21(6)18-34(11-3,42-31)26-16-17-33(40,10-2)23(8)41-26)30(37)22(7)28(35)19(4)12-14-24-15-13-20(5)29(36)27(24)32(38)39/h13,15,19,21-23,25-26,28,31,35-36,40H,9-12,14,16-18H2,1-8H3,(H,38,39)/t19-,21+,22+,23+,25+,26-,28+,31+,33-,34+/m1/s1	N/A	0	Positive	N/A	Other	590.3806	Robin Schmid	[M+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Lasalocid [IIN based]	1198.7965	Orbitrap	LC-ESI	2576	CCC(C1C(CC(O1)(CC)C2CCC(C(O2)C)(CC)O)C)C(=O)C(C)C(C(C)CCC3=C(C(=C(C=C3)C)O)C(=O)O)O	InChI=1S/C34H54O8/c1-9-25(31-21(6)18-34(11-3,42-31)26-16-17-33(40,10-2)23(8)41-26)30(37)22(7)28(35)19(4)12-14-24-15-13-20(5)29(36)27(24)32(38)39/h13,15,19,21-23,25-26,28,31,35-36,40H,9-12,14,16-18H2,1-8H3,(H,38,39)/t19-,21+,22+,23+,25+,26-,28+,31+,33-,34+/m1/s1	N/A	0	Positive	N/A	Other	590.3806	Robin Schmid	[2M+NH4]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Lasalocid [IIN based]	613.3706	Orbitrap	LC-ESI	29	CCC(C1C(CC(O1)(CC)C2CCC(C(O2)C)(CC)O)C)C(=O)C(C)C(C(C)CCC3=C(C(=C(C=C3)C)O)C(=O)O)O	InChI=1S/C34H54O8/c1-9-25(31-21(6)18-34(11-3,42-31)26-16-17-33(40,10-2)23(8)41-26)30(37)22(7)28(35)19(4)12-14-24-15-13-20(5)29(36)27(24)32(38)39/h13,15,19,21-23,25-26,28,31,35-36,40H,9-12,14,16-18H2,1-8H3,(H,38,39)/t19-,21+,22+,23+,25+,26-,28+,31+,33-,34+/m1/s1	N/A	0	Positive	N/A	Other	590.3806	Robin Schmid	[M+Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Lasalocid [IIN based]	573.3778	Orbitrap	LC-ESI	414	CCC(C1C(CC(O1)(CC)C2CCC(C(O2)C)(CC)O)C)C(=O)C(C)C(C(C)CCC3=C(C(=C(C=C3)C)O)C(=O)O)O	InChI=1S/C34H54O8/c1-9-25(31-21(6)18-34(11-3,42-31)26-16-17-33(40,10-2)23(8)41-26)30(37)22(7)28(35)19(4)12-14-24-15-13-20(5)29(36)27(24)32(38)39/h13,15,19,21-23,25-26,28,31,35-36,40H,9-12,14,16-18H2,1-8H3,(H,38,39)/t19-,21+,22+,23+,25+,26-,28+,31+,33-,34+/m1/s1	N/A	0	Positive	N/A	Other	590.3806	Robin Schmid	[M-H2O+H]+	N/A	3	N/A	N/A	N/A	N/A	UK
20191007_salt_addition_IIN_paper_settings.mgf	*..*	Lasalocid [IIN based]	635.3505	Orbitrap	LC-ESI	558	CCC(C1C(CC(O1)(CC)C2CCC(C(O2)C)(CC)O)C)C(=O)C(C)C(C(C)CCC3=C(C(=C(C=C3)C)O)C(=O)O)O	InChI=1S/C34H54O8/c1-9-25(31-21(6)18-34(11-3,42-31)26-16-17-33(40,10-2)23(8)41-26)30(37)22(7)28(35)19(4)12-14-24-15-13-20(5)29(36)27(24)32(38)39/h13,15,19,21-23,25-26,28,31,35-36,40H,9-12,14,16-18H2,1-8H3,(H,38,39)/t19-,21+,22+,23+,25+,26-,28+,31+,33-,34+/m1/s1	N/A	0	Positive	N/A	Other	590.3806	Robin Schmid	[M-H+2Na]+	N/A	3	N/A	N/A	N/A	N/A	UK
